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b-Amyloid (Ab) may play an important role in the pathogenesis of Alzheimer’s disease. However, a
causal relationship between Ab oligomers and layer-speciﬁc neurodegeneration has not been clari-
ﬁed. Here we show up-regulation of calsyntenin (Cst)-3 in cultured neurons treated with Ab oligo-
mers and in Tg2576 mice. Cst-3 is distributed in large neurons in layers 2–3 and 5 of the cerebral
cortex, and accumulated in dystrophic neurites surrounding Ab-plaques. Overexpression of Cst-3
accelerates neuronal death. These results indicate that up-regulation of Cst-3 in cortical neurons
in layers 2–3 and 5 by Ab oligomers may lead to increase in vulnerability of neurons.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Alzheimer’s disease (AD) is characterized by the accumulation
of b-amyloid (Ab) plaques and neuroﬁbrillary tangles, and neuro-
nal loss in the neocortex. Genetic, neuropathological, and biologi-
cal evidence indicates that Ab plays an important role in the
early pathogenesis of AD: cognitive impairment caused by synaptic
dysfunction [1–3]. Despite a poor correlation between Ab-plaque
density and cognitive decline in very mild AD patients, the amount
of soluble Ab oligomer in neocortex correlates well with cognitive
decline or synaptic loss in humans and transgenic mice expressing
mutant human amyloid precursor protein (APP) [4–8]. However,
the molecular mechanisms of synaptic dysfunction by soluble Ab
oligomers remain to be fully elucidated. The identiﬁcation of Ab-
induced genes that mediate synaptic dysfunction would provide
considerable insight into the mechanisms of AD.
Calsyntenins (Cst, also termed alcadeins), type-1 transmem-
brane proteins of the cadherin superfamily, are found in the synap-
tic membrane in the adult brain [9]. Three Csts, Cst-1, Cst-2, and
Cst-3, identiﬁed in human, mouse and rat [10,11], have the WDDS
motif, which binds to the light chain of kinesin-1. In the past fewchemical Societies. Published by E
ease; Cst, calsyntenin; MEN-
.years, biological evidence restricted to Cst-1 has been accumu-
lated; Cst-1 acts as a cargo-docking protein for kinesin-1-mediated
vesicular transport [12,13]. CASY-1, an ortholog of Csts in
Caenorhabditis elegans, plays an important role in learning
[14,15]. The expression of the Cst-1 gene is reduced in amyloid-
rich areas in APP + PS1 Tg mouse brain [16]. In contrast, little is
known about the regulation and the function of other Csts, espe-
cially Cst-3, except their distribution in cerebral cortex [11].
To address these issues, we examined the expression of Cst
genes in Ab-treated neuronal culture, and in the cerebral cortex
from an AD mouse model (APPSW, Tg2576). We also examined
whether altered gene expression causes enhanced vulnerability
of neurons to stimuli leading to neurodegeneration.
2. Materials and methods
2.1. Neuronal cell culture
Cerebral cortices dissected from day E17 embryonic rats were
dissociated by incubation with 0.08% trypsin/0.008% DNase I at
37 C for 10 min, and passed through a 62-lm nylon mesh. The
cells (105 cells/dish for immunoﬂuorescence or 4.5  106 cells/
dish for preparation of RNA or protein) were seeded in gelatin–
polyornithine-coated dishes with 3.5- or 6-cm diameter, respec-
tively, and were cultured in MEM–5% fetal bovine serum–10 lM
b-mercaptoethanol.lsevier B.V. All rights reserved.
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Peptides Ab1-42 and Ab42-1 (Bachem Inc.) were treated with
1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFIP; Sigma), and then dried
under vacuum in a SpeedVac. Freshly prepared Ab1-42 or Ab42-1
was prepared by dissolving the HFIP-treated peptides at 250 lM
in 0.05 N HCl, ﬁltering through a 0.45-lm membrane ﬁlter, and
diluting to 5 lMwith minimum essential mediumwith N2 supple-
ment (MEM-N2). The peptide solution (2 or 5 lM) was added to
the 7 DIV cultures immediately after preparation. Ab1-42 oligo-
mers and ﬁbrils were prepared according to the methods of Stine
et al. [17]. Brieﬂy, Ab1-42 oligomers were prepared by diluting
5 mM Ab1-42 in DMSO to 100 lM in ice-cold Ham’s F12, and incu-
bating at 4 C for 4 days. Ab1-42 ﬁbrils were prepared by diluting
5 mM Ab1-42 in DMSO to 100 lM in 10 mM HCl, and incubating
at 37 C for 4 days. The peptide solution (2 lM) was added to the
7 DIV cultures.
2.3. Mice
Heterozygous Tg2576 (APPSW) mice and wild-type littermates
were purchased from Taconic Farms Inc. Mice were killed by anes-
thesia overdose and perfused transcardially with saline followed
by ice-cold phosphate-buffered 4% paraformaldehyde. After post-
ﬁxation in phosphate-buffered 4% paraformaldehyde for 24 h at
4 C and cryoprotection with 20% sucrose, brains were sectioned
coronally at 10 lm through the entire hippocampus on a cryostat.
2.4. Suppressive subtractive hybridization
Suppressive subtractive hybridization screening was performed
according to the manufacturer’s instructions (Clontech). Brieﬂy,
poly-(A)+RNA from cultured cortical neurons treated with 5 lM
Ab1-42 for 15 h was used as a ‘‘tester’’ and poly-(A)+RNA from cul-
tured cortical neurons treated with MEM-N2 was used as a ‘‘dri-
ver’’. From this screening, we identiﬁed a partial cDNA sequence
(590 bp) corresponding to rat Cst-3 (accession number AJ431642).
2.5. Northern blot analysis
Poly-(A)+RNA from cultured cortical neurons or mouse cerebral
cortex was isolated using a Micro-FastTrack 2.0 Kit (Invitrogen).
Aliquots of 2 lg of poly-(A)+RNA were denatured, electrophoreti-
cally fractionated on a 1.4% agarose/formaldehyde gel, and trans-
ferred to a nylon membrane. Hybridization was performed in a
solution containing cloned cDNA labeled with 32P-dCTP using a
random labeling kit (Roche Applied Science). Radioactivities of
the bands were measured using a Bioimage analyzer BAS 2500.
2.6. Quantitative real-time PCR (QRT-PCR)
First-strand cDNA was synthesized from poly-(A)+RNA of cul-
tured cortical neurons using SuperScript II and oligo (dT) primers
(Invitrogen). Quantitative RT-PCR analysis was performed using
an iCycler iQ Detection System (Bio-Rad) with ELONGase Enzyme
Mix (Invitrogen), SYBR Green I (1/50 000 dilution, Takara), and
400 nM gene-speciﬁc primers (nucleotides 37–60 and 242–219
for Cst-3; nucleotides 201–231 and 284–261 for ACTB). Results
were evaluated with the ICYCLER IQ REAL-TIME DETECTION SYS-
TEM software (Bio-Rad).
2.7. Plasmid constructs
Cst-3 and Cst-2 were constructed by inserting PCR ampliﬁed
fragments into pCMV-Tag5 containing a c-myc epitope (Strata-
gene). Detailed construct information is available upon request.Mouse Cst-1 cDNA clone (clone ID 6315355) was purchased from
OPEN BIOSYSTEMS. The coding fragment of Cst-1 was cloned into
pCMV-Tag5 containing a c-myc epitope (Stratagene).
2.8. Transfection
The constructs were transfected into 5 DIV cortical neurons
with Lipofectamine 2000 according to the manufacturer’s manual
(Invitrogen). For serum withdrawal experiments, the culture med-
ium was replaced with MEN-N2 18 h after transfection and the
cells were cultured for an additional 6, 12, or 24 h.
2.9. Immunoﬂuorescence
Cells were ﬁxed with 4% paraformaldehyde for 10 min at room
temperature, treated with 0.3% triton X-100 for 10 min, blocked
with 2% skim milk for 30 min, and reacted with the primary anti-
bodies for 1 h, followed by a 1 h reaction with the secondary anti-
bodies. Cell nuclei were stained with 10 lM Hoechst 33342 in PBS
() for 10 min. Apoptotic neurons were counted in at least 60
transfected cells for each construct and in each transfection exper-
iment. Immunoﬂuorescence of frozen mouse brain was performed
in the same manner as for cultured cells but followed by treatment
with 10 mM CuSO4 in 50 mM ammonium acetate buffer (pH 5.0)
for 10 min for quenching autoﬂuorescence of lipofuscin pigments
inside neurons in aged mouse brain [18]. Immunoﬂuorescence
was visualized with an Olympus epiﬂuorescence microscope.
2.10. Immunoblotting
Cultured cells were homogenized in 1% NP-40 containing 2 mM
EDTA and protease inhibitors, and centrifuged for 20 min
(14 000 rpm, 4 C). Lysates were analyzed by SDS–PAGE (a 5–15%
acrylamide linear gradient gel). After transferring to Immobilon,
proteins were detected with speciﬁc antibodies using the en-
hanced chemiluminescence method.
2.11. Antibodies
Anti-Cst-3 polyclonal rabbit antibodies were raised against the
peptide SSDERRIIETPPHRY (Cst-3 931–956) conjugated with KLH
at the N-terminus of the peptide. The peptide antibodies were
puriﬁed on the ligand-immobilized EAH Sepharose 4B (GE Health-
care). The polyclonal anti-myc tag antibodies (MBL), polyclonal
anti-APP T668 (Cell Signaling), and a monoclonal anti-PHF anti-
body (AT8, Innogenetics) were purchased. Secondary antibodies
were Texas red-conjugated anti-rabbit IgG (Vector), Alexa 488-
conjugated goat anti-rabbit IgG, and Alexa 594-conjugated goat
anti-mouse IgG1 (Molecular Probe).
3. Results
3.1. Differential regulation of Csts by Ab1-42
The cell viability of rat cortical neurons treated with freshly pre-
pared Ab1-42 assessed by trypan blue exclusion were 91%, 87%,
85%, and 66% of the untreated control after 6, 15, 24, and 48 h of
treatment, respectively [19]. RNA isolated from neuronal cultures
15 h (slight neurodegeneration) after treatment with freshly pre-
pared Ab1-42 was used to generate an Ab-inducing gene library
using PCR-based suppression subtraction hybridization. We identi-
ﬁed Cst-3 as a gene up-regulated by Ab (Fig. 1A and B). Next, to
determine whether other Csts are also up-regulated by Ab, we as-
sessed the expression of Cst-1 and Cst-2 in cortical neurons treated
with freshly prepared Ab1-42 for 15 h. Northern blot analyses
AB
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Fig. 1. Differential regulation of calsyntenin mRNAs by Ab1-42. (A) Northern blot analysis of calsyntenin-1, calsyntenin-2, and calsyntenin-3 in cortical neurons treated with
Ab1-42 for 15 h. (B) Quantiﬁcation of Cst-1 and Cst-2 mRNAs by Northern blotting, and of Cst-3 mRNA by quantitative RT-PCR. Data are the mean ± S.E.M. of three
experiments for Northern blotting and of six experiments for quantitative RT-PCR. ⁄⁄P < 0.001; ⁄⁄⁄P < 0.001 with Student’s t-test compared with the untreated control.
Fig. 2. Oligomeric Ab1-42 increases with the level of calsyntenin-3 protein. (A) Western blot analysis of Ab1-42 preparations. One microgram aliquots of fresh, oligomeric, or
ﬁbrillar preparations were separated by SDS–PAGE on a 10–20% linear gradient gel and analyzed by immunoblotting with anti-Ab antibody 82E2 (recognizing residues 1–16
of Ab). (B) Western blot analysis of calsyntenin-3 in cortical neurons treated with either Ab 42-1 (lanes 1, 5, and 9), fresh (lanes 2, 6, and 10), oligomeric (lanes 3, 7, and 11), or
ﬁbrillar (lanes 4, 8, and 12) Ab1-42 preparations (ﬁnal concentration 2 lM) for 18 h. Synaptophysin was used for the control of equal loading. (C) Quantiﬁcation of
calsyntenin-3 in cerebral cortical neurons treated with Ab42-1 (RP42), fresh (frAb42), oligomeric (oAb42), or ﬁbrillar (fAb42) preparations of Ab1-42 by Western blotting.
Data are the mean ± S.E.M. of three experiments. Statistical signiﬁcance was analyzed by analysis of variance and a post hoc test, ⁄P < 0.05.
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freshly prepared Ab1-42-treated cortical neurons (Fig. 1A and B).
3.2. Aggregation state of Ab is critical for the up-regulation of Cst-3
We examined whether Ab1-42 increases the protein level of
Cst-3 in cortical neurons. The experiments described in the previ-
ous section were conducted using Ab1-42 peptide freshly prepared
in 50 mM HCl. In this section, we examined the ability of Ab1-42
peptide freshly prepared, oligomeric, or ﬁbrillar preparations to in-
duce the expression of Cst-3 protein in cortical neurons. Western
blot analysis of Ab1-42 preparations revealed abundant Ab1-42 tri-
mer and tetramer, and a lesser amount of 50 kDa oligomer in bothfreshly prepared and oligomeric preparations. The ﬁbrillar prepara-
tion contained high-molecular-weight immunoreactivity that did
not enter the resolving gel, but quite little amounts of trimer and
tetramer (Fig. 2A). The treatment of cortical neurons with freshly
prepared or oligomeric but not ﬁbrillar Ab1-42 caused a signiﬁcant
increase in the level of Cst-3 protein (Fig. 2B and C).
3.3. Up-regulation of Cst-3 gene in APPSW transgenic mice
Next, we determined whether the Cst-3 gene is up-regulated in
aged APP mutant mice (APPSW, Tg2576), which contained numer-
ous Ab plaques in the neocortex and hippocampus. Northern blot
analyses revealed up-regulation of Cst-3 but no altered expres-
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Fig. 3. Northern blot analysis of calsyntenin-1, calsyntenin-2, and calsyntenin-3 in
neocortex of 24-month-old wild-type and Tg2576 mice. Data are the mean ± S.E.M.
of three experiments. ⁄P < 0.05 with Student’s t-test compared with wild-type mice.
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(Fig. 3).
To investigate the cellular distribution of Cst-3 in brains from
Tg2576 and wild-type mice, we performed immunoﬂuorescence
of serial frozen tissue sections with antibody against Cst-3. In aged
(21-month-old) wild-type mice, immunoﬂuorescence was de-
tected in neurons in layers 2–6 of neocortex with different ﬂuores-
cence intensities: Intense ﬂuorescence was found in large cortical
neurons in layer 5, with moderate immunoreactivity in large neu-
rons in layers 2–3 and weak immunoreactivity in layers 4 and 6
(Fig. 4A and C). In aged (21-month-old) Tg2576 neocortex, strong
immunoﬂuorescence was observed in dystrophic neurites sur-
rounding Ab plaques, in addition to neuronal distribution
(Fig. 4B, D, and E). Double immunoﬂuorescent analysis revealedFig. 4. Accumulation of calsyntenin-3 immunoreactivity in dystrophic neurites surround
neocortex from 21-month-old wild-type (A) and Tg2576 mice (B) for calsyntenin-3 (gre
neocortex from 21-month-old wild-type (C) and Tg2576 mice (D). (E–G) Immunolabeling
for calsyntenin-3 (green) and Ab (red). (F) Immunolabeling of section adjacent to E with a
and p-tau (AT8, red).that the distribution pattern of Cst-3 in dystrophic neurites is sim-
ilar to that of phospho-APP (T668) but different from that of phos-
phorylated-Tau (AT8) (Fig. 4F and G), suggesting that Cst-3 may be
accumulated in dystrophic neurites of early-stage Ab plaques [20].
3.4. Overexpression of Cst-3 increases vulnerability of cultured cortical
neurons
We examined whether overexpression of Cst-3 in cortical neu-
rons leads to an increase in the vulnerability of cortical neurons
in vitro. Cst-3 with a ﬂag-tag at the N-terminus or a myc-tag at
the C-terminus (Fig. 5A) was generated and expressed in 5 DIV cor-
tical neurons. The expression of exogenous Cst-3 protein was con-
ﬁrmed by Western blotting and immunoﬂuorescence using
antibodies against c-myc and ﬂag (Fig. 5B and C). To determine
whether the overexpression of Cst-3 accelerates cell death after
serumwithdrawal, cortical neurons expressing myc- or ﬂag-tagged
Cst-3 and showing DNA fragmentation were visualized by staining
with anti-myc or anti-ﬂag antibodies and Hoechst 33342 (Fig. 5C).
Fig. 5D shows that cortical neurons expressing Cst-3 with either
myc-tag or ﬂag-tag were more sensitive to serum withdrawal than
those expressing non-toxic MAP1B fragments [19] or untransfec-
ted neurons. It is unlikely that the induction of cell death in
Cst-3-overexpressing neurons was due to a toxic effect of transfec-
tion per se because there was no signiﬁcant difference in cell death
between untransfected neurons and Cst-3-overexpressing neurons
before serum withdrawal (untransfected neurons, 13.8 ± 1.3% cells
were apoptotic 18 h after transfection; overexpression of myc-
tagged Cst-3, 16.9 ± 1.6% cells were apoptotic; overexpression of
ﬂag-tagged Cst-3, 19.4 ± 3.0% cells were apoptotic, mean ± S.E.,
n = 4).ing Ab plaques in neocortex of APPSW (Tg2576) mice. (A–D) Immunolabeling of the
en). Nuclei and Ab plaques were counterstained with Hoechst 33342 (blue) in the
of the neocortex from 21-month-old Tg2576 mice. (E) Double labeling of neocortex
nti-phospho-APP (T668). (G) Double labeling of neocortex for calsyntenin-3 (green)
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Fig. 5. Overexpression of calsyntenin-3 in cerebral cortical neurons accelerates neuronal death. (A) Schematic representation of calsyntenin-3 constructs used in this study.
The myc-tag was attached to the C-terminus of calsyntenin-3, and the ﬂag-tag was attached below the signal peptide sequence of calsyntenin-3. (B) Western blot of
calsyntenin-3 expressed in 5 DIV cortical neurons. The lysates of cortical neurons transfected with the indicated constructs were fractioned by SDS–PAGE on a 5–15% linear
gradient gel and analyzed by immunoblotting with the indicated antibodies. (C) Distribution of Cst-3-myc and ﬂag-Cst-3 overexpressed in cortical neurons. Five DIV cortical
neurons 18 h after transfection with Cst-3-myc (C, 1–3) or ﬂag-Cst-3 (C-4) vectors were examined for immunoﬂuorescence of anti-myc or anti-ﬂag antibodies, respectively.
Nuclei were counterstained with Hoechst 33342. Green arrows indicate intact nuclei and yellow arrowheads indicate apoptotic nuclei. (D) Five DIV cortical neurons were
transfected with Cst-3-myc or ﬂag-Cst-3. Cultured medium was replaced with serum-free medium 18 h after transfection, and cells were cultured for an additional 6 or 12 h.
The number of transfected cells undergoing apoptosis was determined after immunostaining for the myc-tag and Hoechst 33342 staining in at least 60 transfected cells for
each construct in each determination. Data are the mean ± S.E.M. of two independent experiments with ﬁve determinations each. Results are expressed as the percentage of
apoptotic cells among myc-positive cells. ⁄⁄⁄P < 0.0001 by ANOVA and a post hoc test compared with cells transfected with non-toxic MAP1B fragment.
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This study provides evidence for the ﬁrst time that up-regula-
tion of Cst-3 by Ab increases the vulnerability of cortical neurons.
Cst-3 is a type-1 transmembrane protein of the cadherin superfam-
ily and its distribution pattern in cerebral cortex is quite different
from those of other Csts [11]. Cst-3 mRNA is highly expressed in a
subpopulation of neurons in cortical layer 5. In contrast, Cst-1
mRNA is strongly expressed in most neurons throughout the corti-
cal layers, and Cst-2 mRNA is highly expressed in a subpopulation
of neurons in layers 5 and 6. Our immunoﬂuorescence observa-
tions indicated that the most intensive immunoreactivity of Cst-3
is distributed in large neurons in layer 5, with moderate immuno-
reactivity in large neurons in layers 2–3 and weak immunoreactiv-
ity in layers 4 and 6 in wild-type mice. In AD, the pyramidal
neurons in layers 2, 3, and 5 of neocortex are vulnerable to neuro-
nal degeneration [21], despite of Ab-deposits in all six layers.
Although it is exactly unclear whether the layer heterogeneity of
the Ab-susceptibility depends on intrinsic factors in neuron them-
selves, it is possible that cortical neurons expressing a high level of
Cst-3 may be vulnerable to AD degeneration. Indeed, dystrophic
neurites surrounding Ab plaques contained accumulated Cst-3
immunoreactivity.
Our in vitro ﬁnding indicates that Ab oligomer but not ﬁbril up-
regulates Cst-3 expression. This does not conﬂict with the in vivo
ﬁndings showing Cst-3 accumulation in dystrophic neurites sur-
rounding Ab plaques because Ab oligomers are distributed sur-
rounding plaque cores and induce dendritic spine loss and
dystrophic neurites near Ab plaques [22,23]. Thus, it is reasonable
to speculate that Ab oligomers initiates these synaptic degenera-
tion via the up-regulation of Cst-3 in neurons in layers 2–3 and 5
of the cerebral cortex.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.01.025.
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